TRIP13 and cancer: Our findings provided mechanistic insights relevant for the exploitation of future Trip13 inhibitors for cancer therapy by defining Plin2 as predictive marker for the susceptibility of tumors to a respective targeted therapy in the context of a precision medicine approach.